Excitation of accumbal D2 cells governs vital actions, including avoidance of learned risks, but the origins of this excitation and roles of D2 cells in innate risk-avoidance are unclear. Hypothalamic neurons producing orexins (also called hypocretins) enhance innate risk-avoidance via poorly understood neurocircuits. We describe a direct orexin→ D2 excitatory circuit and show that D2 cell activity is necessary for orexin-dependent innate risk-avoidance in mice, thus revealing an unsuspected hypothalamus-accumbens interplay in action selection.
Excitation of accumbal D2 cells governs vital actions, including avoidance of learned risks, but the origins of this excitation and roles of D2 cells in innate risk-avoidance are unclear. Hypothalamic neurons producing orexins (also called hypocretins) enhance innate risk-avoidance via poorly understood neurocircuits. We describe a direct orexin→ D2 excitatory circuit and show that D2 cell activity is necessary for orexin-dependent innate risk-avoidance in mice, thus revealing an unsuspected hypothalamus-accumbens interplay in action selection.
Innate ability to avoid lethal risks is key for survival in all organisms. In mammals, context-appropriate actions such as riskavoidance are computed by the brain, but relations between the underlying neural signals are incompletely understood. Orexin peptides (also called hypocretin peptides) are a fundamental brain system required for context-appropriate brain state control 1, 2 . They are made exclusively by a subset of lateral hypothalamic (LH) neurons, which are activated by diverse internal and external stresses and evoke central and autonomic arousal by releasing orexin at brainwide projections [1] [2] [3] [4] . Previous studies indicate that orexin signals are sufficient and necessary for inducing anxiety-like states, such as increased innate risk-avoidance (a hallmark of anxiety 5 ) in rodents or panic attacks in humans [6] [7] [8] [9] . However, it remains unknown what downstream circuits are essential for innate risk-avoidance driven by natural orexin signals. Among brain areas innervated by orexin LH cells is the nucleus accumbens (NAc) 4 , a central switch for action strategies 10 . The NAc contains dopamine-inhibited D2 NAc neurons 11 ( Supplementary Fig. 1a ,b) whose excitation was recently found to drive avoidance of learned risk 10 . However, it is unclear where the D2 NAc cell excitation physiologically originates and whether it drives innate risk-avoidance.
To test whether D2 NAc cell excitation may originate from orexin LH neurons, we optogenetically photostimulated NAc orexin axons, or applied orexin peptide, while recording from D2 NAc cells in mouse brain slices (Fig. 1a-d and Methods). Orexin stimulations excited D2 NAc cells on a timescale similar to the risk-avoidance-associated D2 NAc cell excitation in vivo 10 , and this excitation was abolished by orexin receptor antagonism (Fig. 1d,e) ; a low-probability fast orexin cell→ D2 cell excitation was also present in some cells ( Supplementary Fig. 1f ). Orexin stimulation did not affect most other NAc cells, such as NAc D1 cells ( Fig. 1e and Supplementary  Fig. 2a,b ; this suggests that the D1 and D2 cells studied here were largely non-overlapping, as also found in ref. 12 ) or NAc fast-spiking or acetylcholine interneurons (optogenetic experiments, n = 12 and 10, respectively, data not shown; orexin peptide experiments, Fig. 1e ). However, orexin stimulation excited NPY NAc interneurons ( Fig. 1e and Supplementary Fig. 1c-e) , which, according to previous work, may indirectly stimulate D2 NAc cells by inhibiting D1 NAc cells 13 . The LH contains melanin-concentrating hormone (MCH) neurons that are distinct from orexin neurons 4 . We found, by rabies-assisted retrograde tracing of direct inputs to D2 NAc cells, that D2 NAcprojecting LH cells are more likely to contain orexin than MCH (Fig. 2) , and optogenetic stimulation of NAc MCH axons did not change D2 NAc cell excitability ( Supplementary Fig. 2c,d ).
Together, these data demonstrate cell-type-specific LH→ NAc 
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circuitry that would be expected to directly and indirectly increase D2 NAc cell activity.
To probe the roles of natural orexin LH and D2 NAc signals in action selection, we quantified the intensity of innate risk-avoidance behavior in two assays (open space and predator-odor avoidance; see Methods), combined with chemogenetic and pharmacological modulation of D2 NAc and orexin signals. Our main aim was to examine behavioral roles of natural (i.e., spontaneously generated by the brain) orexin and D2 NAc cell signals, which we isolated by comparing behavior resulting from natural versus signal-specifically suppressed brain function. Suppression of natural orexin signaling by orexin receptor antagonism (Fig. 3b-e) led to decreased risk-avoidance behaviors (left plots in Fig. 3c ,e, effects indicated in green); notably, these effects were not associated with locomotor sedation (Supplementary Fig. 4e ). Thus, orexin is necessary as well as sufficient 6, 7, 9 for normal innate risk-avoidance (the sufficiency of NAc orexin stimulation for risk-avoidance was further confirmed in our behavioral assays; Supplementary Fig. 3 ). By chemogenetically silencing or stimulating D2 NAc cells ( Fig. 3a and Supplementary Fig. 4a,b) , we also found that D2 NAc cells were necessary (left plots in Fig. 3c ,e, effects indicated in purple) and sufficient ( Supplementary Fig. 4a-d) for normal innate risk-avoidance.
We next examined co-dependencies of risk-avoidance arising from natural orexin or D2 NAc signals by combinatorial silencing of global orexin receptors and local D2 NAc cells. We found that riskavoidance driven by natural orexin signals (isolated by quantifying behavior with and without orexin antagonist in individual mice) was abolished by D2 NAc cell silencing (center plots in Fig. 3c,e) . This indicates that translation of natural orexin signals into innate riskavoidance requires D2 NAc cells and that other orexin-excited cells 1 , including NPY NAc cells identified here, are not sufficient for this translation. Finally, we analyzed whether natural orexin signals are necessary for the behavioral output D2 NAc cells. We found that riskavoidance driven by natural D2 NAc cell activity (isolated by quantifying behavior with and without clozapine-N-oxide (CNO) in individual D2 NAc -hM4Di mice) was substantially reduced by orexin receptor blockade (right plots in Fig. 3c,e) , suggesting that D2 NAc cells regulate behavior according to orexin tone. Thus, orexin is not only sufficient to stimulate D2 NAc cells (Fig. 1d ) but also shapes their behaviorally relevant output in vivo (Fig. 3c,e) .
Overall, we found that an excitatory drive to D2 NAc cells emanates from LH orexin cells and that D2 NAc cells are essential for innate riskavoidance mediated by spontaneously released orexin. These findings also suggest hypotheses for further study. For example, orexin cell activity is implicated in many types of reward seeking 14, 15 , and it is tempting to speculate that the enhanced risk-avoidance caused by orexin may help avoid danger while seeking rewards. Since dopamine inhibits but orexin excites D2 NAc cells, D2 NAc -dependent risk-avoidance may be computed from antagonistic integration of these neurochemical representations of reward and stress. Insights into neuropsychiatric disorders linked to orexin signals 6 will benefit from understanding how this LH system governs molecularly defined brain switches of action strategies.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-017-0023-y.
Targeting genes and recordings. All animal study protocols used in this work were legally and ethically approved by the United Kingdom Government (Home Office Project License PPL 70/7600). Mice were maintained on a 12:12-h light:dark cycle (lights on at 07:00 h) in a temperature-and humidity-controlled (21 ± 2 °C; 50 ± 5%) environment. Food and water were available ad libitum, unless otherwise stated. To manipulate and/or record genetically defined elements of neural circuitry, we used six different transgenic mouse lines and/or their intercrosses. The transgenic mice were obtained from Jackson Labs, from Mutant Mouse Resource Research Centers (MMRRC) or from collaborators (as stated). Specifically, to target D2 neurons, we used A2A-Cre mice (MMRRC founder line KG139), since the A2A receptors are a selective marker of these cells 16, 17 . To target D1R neurons, we used D1-Cre mice (MMRRC founder line EY217) or Drd1a-tdTomato mice (Jackson Strain 016204). To target NPY neurons, we used NPY-hrGFP mice (Jackson Strain 006417). To target opsins to orexin neurons, we used our previously characterized methods in orexin-Cre mice 18, 19 (kind gift from T. Sakurai, Kanazawa University, Japan). To target MCH neurons, we used previously characterized MCH-Cre mice 20 (Jackson Strain 014099). To identify specific NAc neurons for recordings, we used genetically targeted reporters using the above-described mouse lines (also see "Viral vectors" below) and/or determined the previously characterized, NAc cell-type-defining electrical fingerprints of the neurons by analyzing membrane potential responses to current injections [21] [22] [23] [24] (for example, Fig. 1c and Supplementary Fig. 1a,d ) Viral vectors. Mice were stereotaxically injected with AAVs coding for Credependent reporters or actuators (from commercial providers, UNC or Penn Vector facilities) or with custom-made viral vectors facilitating retrograde monosynaptic tracing 3 . Stereotaxic injections (David Kopf digital mouse frame) of viral vectors were performed under isoflurane anesthesia into the LH or NAc shell (as indicated), at the following coordinates. LH: from bregma -1.40 mm, from midline ± 0.90 mm, from brain surface -5.40, -5.20 and -5.00 mm (three injections of 75 nL each at 50 nL/min). We targeted NAc shell (ventromedial NAc) because this area is thought to be particularly important for neural processing relating to action selection [25] [26] [27] , using the following coordinates: from bregma + 1.50 mm, from midline ± 0.80 mm, from brain surface -4.50 mm (one injection of 200 nL or 300 nL at 50 nL/min). Mice were allowed to recover for at least 1 week after surgery whilst singly housed, before any tests. The stereotaxic injection sites were verified by fluorescence microscopy (for electrophysiology-related studies) or by immunohistochemistry (for anatomy and in vivo studies). All 'misses' or 'partial hits' were excluded from data analyses.
To target ChR2 to orexin or D2 neurons, we injected into LH or NAc of orexin-Cre or A2A-Cre mice, respectively, a Cre-dependent ChR2 vector, AAV2/ EF1a-DIO-ChR2(E123T/T159C)-mCherry (7.3 × 10 12 gc/mL, UNC Vector Core). To target the inhibitory or excitatory chemogenetic receptors to D2 cells, we injected the NAc shell of A2A-Cre mice with Cre-dependent DREADD vectors, respectively: rAAV8/hSyn-DIO-hM4(Gi)-mCherry (5.3 × 10 12 gc/mL, UNC Vector Core) or rAAV8/hSvn-DIO-hM3D(Gq)-mCherry (5.3 × 10 12 gc/mL, UNC Vector Core). For retrograde rabies tracing of inputs to D2 cells, we injected into the NAc shell of A2A-Cre mice a 200-nL mix of Cre-dependent helper viruses (AAV2/1-Flex-C-RVG, Addgene 49101; and AAV2/1-EF1a-Flex-eGFP-TVA, Addgene 26198) followed 2 d later by a 150-nL NAc injection of modified, glycoproteindepleted Δ RV-RFP virus 28, 29 . These viruses and the monosynaptic retrograde tracing method are described in detail in refs 3, [28] [29] [30] .
Optogenetics and electrophysiology. Whole-cell slice patch-clamp recordings, in combination with optical excitation of ChR2-expressing cells, were performed using standard techniques, as in our previous work 31, 32 . Briefly, brain slices were prepared at least 4 weeks after stereotaxic virus injection, from 8-to 12-week-old male and female mice. Mice were quickly killed by cervical dislocation, and their brains were removed and glued onto a stage. Acute coronal (LH) or sagittal (NAc) slices 250 µ m thick were cut whilst immersed in ice-cold ACSF slicing solution using a Peltier-cooled Campden Vibroslice. Slices were then transferred to a submerged-type chamber and incubated for 30 min in ACSF at 35 °C, and then at room temperature (25 °C) until used for recording. Fluorescent neurons were visualized in acute brain slices with an upright Olympus BX51WI microscope equipped with an oblique condenser and appropriate fluorescence filters. Excitation light for ChR2 was delivered using a LAMBDA DG-5 fast beam switcher (Sutter Instruments) with a xenon lamp and ET470/40-nm bandpass filter. A 40× 0.8 NA objective was used to deliver brief, 5-ms flashes of blue light (∼ 10 mW/ mm 2 ) onto ChR2-containing axons around the recorded cell while monitoring postsynaptic currents or membrane potential to map the connectivity between LH and NAc neurons. To probe a connection, pulses were typically delivered at 20 Hz, as indicated in the figures, and each cell was tested in voltage-clamp mode at a range of holding potentials (0 to -80 mV), as well as in current-clamp mode. Functional expression of ChR2 in LH neurons was confirmed by observation of light-evoked action potentials in somatic recordings from orexin LH -ChR2(E123T/ T159C)-mCherry neurons (data not shown).
To assess direct effects of bath-applied orexin-A peptide on NAc neurons, we performed whole-cell current-clamp recordings in the presence of synaptic d-AP5, 50 µ M) . To confirm the effect of CNO on D2-hM4Di-mCherry or on D2-hM3Dq-mCherry neurons, CNO was bath-applied during whole-cell current-clamp recordings. In some voltage-clamp recordings, cells were injected with repetitive pulses of small hyperpolarizing current in order to monitor changes in membrane resistance ( Fig. 3a and Supplementary Fig. 4b ).
Chemicals and solutions. All drugs were from Sigma unless indicated otherwise. Artificial cerebrospinal fluid (ACSF) and the ice-cold slicing solutions were gassed with 95% O 2 and 5% CO 2 , and they contained the following, in mM: ACSF: 125 NaCl, 2. For slice experiments, drugs were used at the following final concentrations: orexin-A, 300 nM; MCH, 1 μ M; clozapine-N-oxide (CNO), 5 µ M; synaptic blocker mix: D-AP5, 50 µ M; picrotoxin, 10 µ M; CNQX, 10 µ M; CGP 35348, 10 µ M; gabazine, 3 µ M (Tocris); NBQX, 10 μ M (Tocris); orexin receptor blocker mix: SB 334867, 10 μ M; TCS-OX2-29, 10 μ M (Tocris). Clozapine-N-oxide (CNO) was administered i.p. at 5 mg/kg for animals expressing hM4Di and 0.5 mg/kg for animals expressing hM3Dq.
Animal behavior and chemogenetics. Adult male mice were used for all behavioral experiments. They were kept on a standard 12-h light-dark cycle (lights on at 07:00) and on standard mouse chow and water ad libitum. Animals of the same genotype were grouped according to the vectors injected into their brains, and all groups had similar compositions based on sex (males), age and body weight. Mouse groups in behavioral experiments were matched by age and weight. For in vivo cell-type-specific manipulation, CNO or saline was administered i.p. For orexin-receptor activity manipulation, the competitive orexin receptor antagonist SB-334867 (or control vehicle: 0.9% NaCL in 10% DMSO) was administered i.p. This antagonist has a higher affinity for orexin type-1 receptors than for orexin type-2 receptors, but at higher concentrations, such as used here, it antagonizes orexin binding to both receptors 33 . We used a single high dose (30 mg/kg) of SB-334867, based on previous studies with this compound 34, 35 .
SB-334867 was given 2 h before behavioral tests and CNO was given 30 min before behavioral tests.
The open field center-border exploration test (Fig. 3b) was conducted in an open arena made of opaque Plexiglas (50 × 50 cm floor area), which was dimly illuminated. This test is an established assay for measuring anxiety and exploration in a novel environment, because rodents innately stay close to walls and avoid open areas (in this case, the center) associated with greater risk of being discovered by predators 36, 37 . After drug or saline treatments, each mouse was placed gently on the central zone, and its behaviors were recorded by a camera for 15 min and analyzed by Ethovision XT software version 11 (Noldus). Time spent in the center area (marked in Fig. 3b ) and in the border area (area outside the center) of the openfield apparatus was quantified by automated video tracking (Ethovision XT), and the percentage of time spent in the center of the arena was calculated. Tests were conducted between 10:00 and 15:00 h. Each individual mouse was tested once per week to maintain the effect of novelty, and within mouse groups, saline and CNO trials were interleaved.
The predator-odor risk-taking task (PORT; Fig. 3d ) was performed as described by Dent et al. 38 , with minor modifications. In this model, mice balance the benefit of gaining a food reward with the innately perceived risk of exposure to a predator 38 . Mice had to cross a three-chamber cage to collect a reward and were required to pass through a compartment containing a predator (fox) odor. Innate fear is a basic and natural mechanism by which organisms evade danger, and a volatile chemical produced by foxes, trimethylthiazoline (TMT), incites innate avoidance behavior in mice 39, 40 . The PORT apparatus consisted of an arena (60 × 40 cm floor area) longitudinally divided into three equal chambers, such that the middle chamber could be entered from either of the side chambers (Fig. 3d) . At the start of the trial, the mouse was placed in either the left or right chamber, such that some mice moved from left to right and others right to left, but direction was fixed for each individual subject throughout testing. For each trial, 250 mL bedding was distributed evenly over the floor of the middle chamber. For control trials, clean bedding was used. For test trials, 'fox-odor' bedding was used; this was produced by impregnating the bedding with a 10% solution of TMT analogue 2,4,5-trimethylthiazole. A reward (a small cup of milkshake) was placed in a pot in the center of the reward chamber. Tests were conducted between 10:00 and 15:00 h. All animals participating in the PORT experiment were food-deprived overnight previous to the test day. Data were collected using the EthoVision software with a specific virtual arena and zone configuration. During habituation trials, no bedding or reward was present, and mice were placed in the center of the middle compartment of the PORT cage and allowed to explore the three chambers for 5 min per day across a 3-d period; no chamber preferences were found during habituation (data not shown). During acquisition trials, mice were placed in one of the outer chambers ('start'), the doors were opened and the subject was free to explore the three chambers and collect the reward (milkshake) situated on the opposite ('reward') chamber. The trial was stopped when the mouse was observed to have collected the reward.
Immunohistochemistry. Brain slices (250 µ m thick) containing the NAc and/or LH were fixed in 4% PFA in PBS overnight. After washing with PBS, slices were either mounted with Vectashield hard-setting medium (with DAPI staining) or stained with goat primary antibody to orexin-A (sc-8070, 1:2,000, Santa Cruz Biotechnology) and Cy3-conjugated AffiniPure F(ab´)2 fragment donkey anti-goat secondary label (705-166-147, 1:500, Jackson ImmunoResearch) or with rabbit primary antibody to MCH (1:1,000, Phoenix Pharmaceuticals, Burlingame, CA) and Alexa Fluor-594 donkey anti-rabbit secondary antibody (H-070-47, 1:1,000; Thermo Fisher). The antigens we stained (orexin and MCH) are biologically found exclusively in the LH cells, and thus an absence of staining in extra-hypothalamus regions served as a reasonable control for antibody specificity; in addition, the primary antibodies were validated by observing lack of staining in brains of orexin-or MCH-cell knockout mice 41, 42 . Slices were imaged with an Olympus VS120 slide scanner or an Olympus BX61WI laser scanning confocal microscope. Histochemical analysis of rabies-traced brains was performed as in our previous work 3 .
Cannula surgery and NAc drug microinfusions. For administration of orexin into NAc (Supplementary Fig. 3 ), bilateral guide cannulae (Plastics One) were implanted at the same coordinates as for the viral injections (from bregma + 1.50 mm, from midline ± 0.80 mm, from brain surface -4.50 mm). After surgery, animals were allowed to recover for at least 1 week whilst singly housed. Handling for drug microinfusions began the week before any behavioral tests. Animals were handled daily and subject to at least 3 mock injections to habituate them to the injection procedure. Orexin-A (Tocris, 1455) was dissolved in a vehicle solution (ACSF, Tocris, 3525). Mice received microinjections of either vehicle or orexin-A (1 nM/50 nL) 30 min before behavioral tests. Drugs were delivered via injector cannulae bilateral infusion needles (Plastics Ones) at a rate of 50 nL/min. Injector was left in place for an additional 1 min before retraction to allow for complete drug diffusion.
Quantifying behavior driven by natural genetically defined neural activity.
Anxiety-like behavior driven by specific, endogenous neural signals was isolated and quantified as follows. Orexin-dependent center avoidance (Fig. 3c) was calculated for each D2-hM4Di mouse by subtracting the percent of time spent in the center after injection of saline from the the percent of time spent in the center after the orexin antagonist SB-334867. D2 cell-dependent center avoidance (Fig. 3c) was calculated for each D2-hM4Di mouse by subtracting the percent of time spent in the center after injection of saline from the the percent of time spent in the center after injection of the D2-hM4Di cell silencer CNO. Orexin-dependent hesitation (i.e., latency) to entry into the fox-bedding chamber (Fig. 3e) was calculated for each D2-hM4Di mouse by subtracting the latency after injection of SB-334867 from the latency after injection of saline. D2 cell-dependent hesitation (Fig. 3e) was calculated for each D2-hM4Di mouse by subtracting the latency after injection of CNO from the latency after injection of saline.
Statistical analysis, blinding and randomization. Data were analyzed using Origin Pro 8.6 (OriginLab), Prism 6.0 (GraphPad), ImageJ and Ethovision XT (Noldus) software packages. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications 1, 12 . The heatmaps depicting spatial exploration (Fig. 3b,d and Supplementary Fig. 4c) were produced using the 'over heatmaps' setting of Ethovision, in which a color represents the same location frequency (occupancy) within each set of heatmaps. Before performing parametric tests, data were tested for normality with a D' Agostino-Pearson omnibus test or Kolmogorov-Smirnov test for small sample sizes, and variances were tested for homogeneity with Bartlett's test; based on results of these tests, appropriate data transformations were made where necessary to meet the normality and homoscedasticity assumptions of parametric tests. In slice recordings, cells were randomly sampled throughout the full anatomical extent of NAc shell, by choosing cells for recording using an objective that blinded the investigator to the exact intra-NAc-shell location of the cell due to its small field of view (40× objective). After recording, the location of the recorded cell was confirmed using a low-magnification large-field objective. In behavioral experiments, the treatments and genotypes of mouse groups were interleaved during trials in a Latin square design to avoid any order effects. Within this design, each possible treatment was represented during each session and each animal received all possible treatments across sessions. Animals were randomly assigned to a particular order of treatments. Data collection and analysis were performed blind to the conditions of the experiments. Data extraction from videos was fully automated (EthoVision XT) to maximize objectivity and reproducibility. No data were excluded from analyses.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. The data that support the findings of this study are available from the corresponding author upon reasonable request. 
Replication
Describe whether the experimental findings were reliably reproduced.
yes, they were replicated in an appropriate number of cells and animals, as specifically described in figure legends and text
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
1) In slice recordings, cells were randomly sampled throughout the full anatomical extent of NAc shell, by choosing cells for recording using an objective that blinded the investigator to exact intraNAc-shell location of the cell due to its small field of view (high-magnification objective (x40) objective). After recording, the location of recorded cell was confirmed using a low-magnification large-field objective.
2) In whole-animal analyses, animals of the same genotype were grouped according to vectors injected into their brains, and all groups had similar compositions based on sex (males), age, and bodyweight. Trials were interleaved in a Latin square to avoid order effects.
The above is explained in "Statistical analysis, blinding, randomization" Section of Supplementary Methods
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
In slice recordings, cells were selected using an objective that blinded the investigator to exact intra-NAc-shell location of the cell due to its small field of view (x40 objective). In behavioral experiments, data collection and analysis were performed blind to the conditions of the experiments.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section) Describe the software used to analyze the data in this study.
Data were analysed using commercial software: Origin Pro 8.6 (OriginLab), Prism 6.0 (GraphPad), ImageJ, and Ethovision XT (Noldus). No custom codes were used.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
all materials are commercially available June 2017
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Commercial antibodies were used, which were validated in our system (mouse brain) both in previous publications, and within this study, as follows: In addition, we performed further checks of antibody specificity based on the following logic. The antigens we stained (orexin and MCH) are biologically found exclusively in the LH cells, and thus no staining in extra-hypothalamus regions served as a reasonable control for antibody specificity. We also tested the relevant antibodies in the same brains, and found no colocalisation between them, as expected from the biological reality (orexin and MCH peptides are biologically found in separate cells).
The specificity of secondary labels was confirmed by observing lack of cell body staining in mouse brain slice preparations where the primary antibody was omitted. 
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
mice, different genetic strains (as described in detail in Supplementary Methods), male and/or female (as specified for different experiments in Supplementary Methods), age 8-12 week old (adult).
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
the study did not involve human research participants
